Viewing Study NCT02257359


Ignite Creation Date: 2025-12-24 @ 3:00 PM
Ignite Modification Date: 2026-02-03 @ 3:55 AM
Study NCT ID: NCT02257359
Status: COMPLETED
Last Update Posted: 2018-09-13
First Post: 2014-10-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Embryo Transfer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epelsiban View
None Healthy Female Volunteers View
None Safety View
None Tolerability View
None Oxytocin View
None Pharmacokinetics View